Kun Meng
Chief Executive Officer at Beijing Shenogen Pharma Group Ltd.
Kun Meng active positions
| Companies | Position | Start | End |
|---|---|---|---|
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Chief Executive Officer | - | - |
| Chairman | - | - | |
| Founder | - | - |
Career history of Kun Meng
Training of Kun Meng
| University of Chinese Academy of Sciences | Doctorate Degree |
| Harvard University | Graduate Degree |
Statistics
International
| China | 3 |
| United States | 2 |
Operational
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Kun Meng
- Experience
